Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BELANTAMAB MAFODOTIN vs BELUMOSUDIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BELANTAMAB MAFODOTIN vs BELUMOSUDIL: Safety Overview

Metric BELANTAMAB MAFODOTIN BELUMOSUDIL
Total FAERS Reports 2,293 2,604
Deaths Reported 843 223
Death Rate 36.8% 8.6%
Hospitalizations 599 700
Average Patient Age 67.3 yrs 54.3 yrs
% Female Patients 39.2% 46.7%
FDA Approval Date N/A Jul 16, 2021
Manufacturer GlaxoSmithKline LLC Kadmon Pharmaceuticals, LLC
Route INTRAVENOUS ORAL
Marketing Status N/A Prescription